Lemaitre Vascular [LMAT] vs AptarGroup [ATR] Detailed Stock Comparison

Lemaitre Vascular Inc.

NASDAQ
Loading...

AptarGroup, Inc.

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: Lemaitre Vascular Inc. wins in 9 metrics, AptarGroup, Inc. wins in 12 metrics, with 0 ties. AptarGroup, Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Lemaitre Vascular Inc. AptarGroup, Inc. Better
P/E Ratio (TTM) 44.80 21.10 AptarGroup, Inc.
Price-to-Book Ratio 6.53 2.99 AptarGroup, Inc.
Debt-to-Equity Ratio 47.16 57.10 Lemaitre Vascular Inc.
PEG Ratio 1.18 -0.84 Lemaitre Vascular Inc.
EV/EBITDA 32.62 11.41 AptarGroup, Inc.
Profit Margin (TTM) 23.13% 10.40% Lemaitre Vascular Inc.
Operating Margin (TTM) 21.77% 11.25% Lemaitre Vascular Inc.
EBITDA Margin (TTM) 21.77% 11.25% Lemaitre Vascular Inc.
Return on Equity 15.80% 15.10% Lemaitre Vascular Inc.
Return on Assets (TTM) 6.76% 6.66% Lemaitre Vascular Inc.
Free Cash Flow (TTM) $74.47M $294.56M AptarGroup, Inc.
Dividend Yield 0.97% 1.38% AptarGroup, Inc.
1-Year Return 15.15% -26.86% Lemaitre Vascular Inc.
Price-to-Sales Ratio (TTM) 10.33 2.11 AptarGroup, Inc.
Enterprise Value $2.40B $9.17B AptarGroup, Inc.
EV/Revenue Ratio 9.61 2.43 AptarGroup, Inc.
Gross Profit Margin (TTM) 71.66% 35.13% Lemaitre Vascular Inc.
Revenue per Share (TTM) $11 $57 AptarGroup, Inc.
Earnings per Share (Diluted) $2.52 $5.88 AptarGroup, Inc.
Beta (Stock Volatility) 0.67 0.49 AptarGroup, Inc.
Short % of Float 7.34% 2.60% AptarGroup, Inc.

Lemaitre Vascular Inc. vs AptarGroup, Inc. Stock Performance Analysis

Loading Price Chart...

LMAT
ATR

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Lemaitre Vascular Inc.0.02%-4.26%-17.83%-15.03%7.91%14.31%
AptarGroup, Inc.0.31%-2.40%-6.69%-19.48%-7.81%-8.17%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Lemaitre Vascular Inc.15.15%45.82%84.43%536.52%1,252.14%1,367.44%
AptarGroup, Inc.-26.86%1.48%-20.41%50.06%126.49%340.16%

Performance & Financial Health Analysis: Lemaitre Vascular Inc. vs AptarGroup, Inc.

MetricLMATATR
Market Information
Market Cap i$2.59B$7.99B
Market Cap CategoryMid capMid cap
10 Day Avg. Volume i168,105382,100
90 Day Avg. Volume i227,868472,420
Last Close$91.64$112.53
52 Week Range$79.01 - $118.01$103.23 - $164.28
% from 52W High-22.35%-31.50%
All-Time High$118.12 (Apr 14, 2026)$178.03 (Nov 11, 2024)
% from All-Time High-22.42%-36.79%
Growth Metrics
Quarterly Revenue Growth0.16%0.14%
Quarterly Earnings Growth0.39%-0.26%
Financial Health
Profit Margin (TTM) i0.23%0.10%
Operating Margin (TTM) i0.22%0.11%
Return on Equity (TTM) i0.16%0.15%
Debt to Equity (MRQ) i47.1657.10
Cash & Liquidity
Book Value per Share (MRQ)$17.28$41.56
Cash per Share (MRQ)$15.77$6.36
Operating Cash Flow (TTM) i$81.25M$570.00M
Levered Free Cash Flow (TTM) i$47.35M$205.90M
Dividends
Last 12-Month Dividend Yield i0.97%1.38%
Last 12-Month Dividend i$1.05$1.86

Valuation & Enterprise Metrics Analysis: Lemaitre Vascular Inc. vs AptarGroup, Inc.

MetricLMAT (Apr 26, 2026)ATR (Apr 26, 2026)
Price Ratios
P/E Ratio (TTM) i44.8021.10
Forward P/E i35.4519.49
PEG Ratio i1.18-0.84
Price to Sales (TTM) i10.332.11
Price to Book (MRQ) i6.532.99
Market Capitalization
Market Capitalization i$2.59B$7.99B
Enterprise Value i$2.40B$9.17B
Enterprise Value Metrics
Enterprise to Revenue i9.612.43
Enterprise to EBITDA i32.6211.41
Risk & Other Metrics
Beta i0.670.49
Book Value per Share (MRQ) i$17.28$41.56

Financial Statements Comparison: Lemaitre Vascular Inc. vs AptarGroup, Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricLMAT (2025)ATR (2025)
Revenue/Sales i249.60M3.78B
Cost of Goods Sold i71.06M2.37B
COGS % of Revenue i28.5%62.8%
Gross Profit i178.54M1.40B
Gross Margin i71.5%37.2%
Research & Development i14.14MN/A
Operating Income (EBIT) i67.91M510.88M
Operating Margin i27.2%13.5%
EBITDA i77.69M841.80M
EBITDA Margin i31.1%22.3%
Pre-Tax Income i75.18M491.38M
Pre-Tax Income % of Revenue i30.1%13.0%
Income Tax i17.45M98.88M
Income Tax % of Revenue i7.0%2.6%
Net Income (Profit) i57.73M392.50M
Profit Margin i23.1%10.4%

Balance Sheet & Liquidity Metrics

MetricLMAT (2025)ATR (2025)
Cash & Equivalents i28.24M402.42M
Total Current Assets i468.23M1.89B
Total Current Assets % of Revenue i187.6%50.1%
Total Current Liabilities i36.32M1.17B
Total Current Liabilities % of Revenue i14.6%30.9%
Long-Term Debt i182.65M1.19B
Long-Term Debt % of Revenue i73.2%31.4%
Total Shareholders Equity i393.52M2.71B
Retained Earnings i184.72M2.64B
Retained Earnings % of Revenue i74.0%70.0%
Property, Plant & Equipment i41.92M65.70M

Cash Flow Statement Comparison

MetricLMAT (2025)ATR (2025)
Operating Cash Flow i73.19M590.78M
Operating Cash Flow % of Revenue i29.3%15.6%
Capital Expenditures i-6.78M3.55M
Free Cash Flow i74.47M294.56M
FCF Margin i29.8%7.8%
Debt Repayment iN/A-194.78M
Common Stock Repurchase iN/A-365.01M

Short Interest & Institutional Ownership Analysis

MetricLMATATR
Shares Short i1.33M1.46M
Short Ratio i4.882.79
Short % of Float i7.34%2.60%
Shares Outstanding i22.77M64.21M
Float Shares i21.15M63.80M
% Held by Insiders i6.89%0.80%
% Held by Institutions i97.09%96.42%
% Held by Public i-3.98%2.78%

Dividend Analysis & Yield Comparison: Lemaitre Vascular Inc. vs AptarGroup, Inc.

MetricLMATATR
Last 12-Month Dividend i$1.05$1.86
Last 12-Month Dividend Yield i0.97%1.38%
3-Year Avg Annual Dividend i$0.75$1.74
3-Year Avg Dividend Yield i0.23%0.32%
3-Year Total Dividends i$2.25$5.23
Ex-Dividend DateMar 12, 2026Feb 04, 2026